Quipt Home Medical (NASDAQ:QIPT) Given “Sell (E+)” Rating at Weiss Ratings

Quipt Home Medical (NASDAQ:QIPT)‘s stock had its “sell (e+)” rating reiterated by analysts at Weiss Ratings in a research report issued on Wednesday,Weiss Ratings reports.

Several other research analysts also recently commented on the stock. Canaccord Genuity Group raised their price target on shares of Quipt Home Medical from $1.70 to $2.30 and gave the company a “hold” rating in a report on Tuesday, August 19th. Wall Street Zen raised shares of Quipt Home Medical from a “sell” rating to a “hold” rating in a report on Saturday, August 16th. One equities research analyst has rated the stock with a Buy rating, one has issued a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat.com, the company has an average rating of “Hold” and an average price target of $3.15.

Quipt Home Medical Stock Up 0.4%

Shares of NASDAQ:QIPT opened at $2.56 on Wednesday. The firm has a fifty day moving average price of $2.48 and a two-hundred day moving average price of $2.16. The company has a debt-to-equity ratio of 0.71, a current ratio of 1.15 and a quick ratio of 0.75. Quipt Home Medical has a one year low of $1.35 and a one year high of $3.27. The company has a market cap of $111.22 million, a price-to-earnings ratio of -10.67 and a beta of 0.60.

Quipt Home Medical (NASDAQ:QIPT) last announced its quarterly earnings results on Monday, August 11th. The company reported ($0.07) EPS for the quarter, missing the consensus estimate of $0.03 by ($0.10). Quipt Home Medical had a negative net margin of 4.30% and a negative return on equity of 9.78%. The firm had revenue of $58.30 million during the quarter, compared to the consensus estimate of $80.37 million. Analysts anticipate that Quipt Home Medical will post -0.05 EPS for the current fiscal year.

Hedge Funds Weigh In On Quipt Home Medical

Several institutional investors and hedge funds have recently made changes to their positions in the business. Jane Street Group LLC grew its holdings in shares of Quipt Home Medical by 207.3% during the 2nd quarter. Jane Street Group LLC now owns 163,175 shares of the company’s stock valued at $293,000 after purchasing an additional 110,070 shares during the last quarter. Diversify Advisory Services LLC bought a new position in shares of Quipt Home Medical during the 2nd quarter valued at $29,000. Qube Research & Technologies Ltd bought a new position in shares of Quipt Home Medical during the 2nd quarter valued at $116,000. Pale Fire Capital SE grew its holdings in shares of Quipt Home Medical by 86.7% during the 2nd quarter. Pale Fire Capital SE now owns 460,303 shares of the company’s stock valued at $824,000 after purchasing an additional 213,807 shares during the last quarter. Finally, Marshall Wace LLP bought a new position in shares of Quipt Home Medical during the 2nd quarter valued at $162,000. Institutional investors own 42.85% of the company’s stock.

About Quipt Home Medical

Quipt Home Medical Corp., through its subsidiaries, engages in the provision of durable and home medical equipment and supplies in the United States. The company offers nebulizers, oxygen concentrators, and CPAP and BiPAP units; traditional and non-traditional durable medical respiratory equipment and services; non-invasive ventilation equipment, supplies, and services; and engages in the rental of medical equipment.